Nimotuzumab: Preliminary Phase II data

Nimotuzumab is available in the U.S. on a compassionate use basis to treat pediatric glioma and has Orphan Drug designation in the U.S. and Europe to treat adult and pediatric glioma. YM BioSciences l...